Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02853604
Title Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer (AIM2CERV)
Acronym AIM2CERV
Recruitment Terminated
Gender female
Phase Phase III
Variant Requirements No
Sponsors Advaxis, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ESP | CAN | BRA | ARG


No variant requirements are available.